Failure of postnatal closure of the ductus arteriosus (DA) remains a common complication of very preterm birth. About a third of infants born before 30 weeks gestation will develop clinical signs ...

Current Controversies in the Diagnosis and Treatment of Patent Ductus Arteriosus in Preterm Infants Nick Evans, DM, MRCPCH Disclosures Adv Neonatal Care. 2003;3 (4) 0 ...

Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management, a ...

More information: Namasivayam Ambalavanan et al, Patent Ductus Arteriosus in Preterm Infants, Pediatrics (2025). DOI: 10.1542/peds.2025-071425 ...

Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants. Quiver AI Summary Merit Medical Systems, Inc. has ...

Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infantsSOUTH JORDAN, Utah, March 10 ...

The diagnosis of patent ductus arteriosus with reversal of flow having been established, operation was decided on but was delayed for 3 months because an unexplained fever (temperature of 100 to ...

Patent ductus arteriosus (PDA) is the most common cardiac condition in infants born before term, with the incidence of PDA inversely related to gestational age. 1 Although PDAs may become evident ...

CHDs are the most common type of congenital condition, seen in about 1% of all newborns in the United States. CHDs range in severity; some mild CHDs resolve on their own, but complicated ...

Mirza H, Garcia J, McKinley G, et al. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants. J Perinatol 2019;39:1648-1655.